Dasatinib and Quercetin Alleviate Retinal Ganglion Cell Dendritic Shrinkage and Promote Axonal Regeneration in Mice with Optic Nerve Injury
Xin Bin, Shuyi Zhou, Yanxuan Xu, Si Chen, Shaowan Chen, Wen Yao, Yingjie Cao, Kunliang Qiu, Tsz Kin Ng · 2025
Read Dasatinib and Quercetin Alleviate Retinal Ganglion Cell Dendritic Shrinkage and Promote Axonal Regeneration in Mice with Optic Nerve Injury by Xin Bin, Shuyi Zhou, Yanxuan Xu, Si Chen, Shaowan Chen, Wen Yao, Yingjie Cao, Kunliang Qiu, Tsz Kin Ng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12733733.txt.
Description
Xin Bin and eight co-authors tested two age-clearing drugs on eye nerve injury in mice, in a study published in 2025. Crush injury to the optic nerve kills its cells in steps and blinds. The past work of the team tied cell aging to the pace of death. Their drugs clear aged cells. Live scans tracked the branch trees of the nerve cells and their long cords over time.
Each drug, alone or paired, cut branch shrinkage compared with plain care. Both also sped cord regrowth past the crush site. Gene readings flagged a growth gene that rose with drug care, a strong hint at the path. The authors say the pair may mend branches and cords in nerve crush care. Human tests would be the next gate.
Catalog record
| CREATOR | Xin Bin, Shuyi Zhou, Yanxuan Xu, Si Chen, Shaowan Chen, Wen Yao, Yingjie Cao, Kunliang Qiu, Tsz Kin Ng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |